|Year : 2013 | Volume
| Issue : 4 | Page : 440-444
Experimental study on effect of hydroalcoholic extract of Emblica officinalis fruits on glucose homeostasis and metabolic parameters
Snehal S Patel1, Ramesh K Goyal2, Rajendra S Shah3, Pravin R Tirgar4, Pinakin D Jadav5
1 Assistant Professor, Department of Pharmacology, Institute of Pharmacy, Nirma University, Ahmedabad, India
2 Distinguish Professor, Department of Pharmacology, Institute of Life Science, Ahmedabad University, Ahmedabad, India
3 Managing Director, Department of Pharmacology, Rajsha Pharmaceuticals, Ahmedabad, India
4 Assistant Professor, Department of Pharmacology, School of Pharmacy, R.K. University, Rajkot, India
5 Assistant Professor, Department of Pharmacology, S.J. Thakker Pharmacy College, Rajkot, Gujarat, India
|Date of Web Publication||21-Feb-2014|
Ramesh K Goyal
Distinguish Professor, Department of Pharmacology, Institute of Life Science, Ahmedabad University, Ahmedabad - 380 009, Gujarat
Source of Support: None, Conflict of Interest: None
| Abstract|| |
Polyphenols from natural source are potential therapeutics that act alone or supplement anti-diabetic drugs in the prevention and treatment of diabetes. The present investigation was undertaken to study the effect of hydroalcoholic extract (HE) of fruits of Emblica officinalis on type 1 diabetic rats. Diabetes was induced by streptozotocin (STZ) (45 mg/kg i.v.). HE (100 mg/kg, p.o.) was administered for 4 weeks and at the end of treatment, blood samples were collected and analyzed for various biochemical parameters. STZ produced a diabetic state exhibiting all the cardinal symptoms such as loss of body weight, polydipsia, polyuria, glucosuria, polyphagia, hypoinsulinemia, and hyperglycemia associated with hypercholesterolemia and hypertriglyceridemia. Treatment with HE prevented cardinal symptoms and caused significant decrease in fasting serum glucose, AUC glucose , cholesterol, triglyceride, low-density lipoprotein (LDL) and very LDL in diabetic rats. However, insulin, AUC insulin , and serum high-density lipoprotein level were not significantly altered by treatment. Treatment also reduced lipid peroxidation and increased anti-oxidant parameters in the liver homogenates of diabetic rats. Polyphenol enriched fraction of HE significantly improved disarranged carbohydrate and lipid metabolism of chemically induced diabetes in rats. The mechanism of its anti-diabetic activity appears to be either improvement in peripheral glucose utilization, increased insulin sensitivity, or anti-oxidant property.
Keywords: Anti-diabetic, anti-hyperlipidemic, anti-oxidant, Emblica officinalis, oxidative stress, polyphenol, streptozotocin
|How to cite this article:|
Patel SS, Goyal RK, Shah RS, Tirgar PR, Jadav PD. Experimental study on effect of hydroalcoholic extract of Emblica officinalis fruits on glucose homeostasis and metabolic parameters. AYU 2013;34:440-4
|How to cite this URL:|
Patel SS, Goyal RK, Shah RS, Tirgar PR, Jadav PD. Experimental study on effect of hydroalcoholic extract of Emblica officinalis fruits on glucose homeostasis and metabolic parameters. AYU [serial online] 2013 [cited 2021 Mar 2];34:440-4. Available from: https://www.ayujournal.org/text.asp?2013/34/4/440/127731
| Introduction|| |
Diabetes mellitus is a serious complex chronic condition that is a major source of ill health worldwide. Fruits of Emblica officinalis Gaertn. (family Euphorbiaceae) commonly known as "Amla" or the Indian gooseberry, have been reported to contain constituents with variable biological activities such as anti-oxidant, adaptogenic, hepatoprotective, anti-tumor, anti-atherosclerosis, immunomodulatory, gastroprotective, hypolipidemic, cyto-protective, and immunomodulating activities.  The fruits of E. officinalis are used in many medicinal preparations of Ayurvedic and Unani systems of medicine.  According to the two main classic texts on Ayurveda, Charaka Samhita and Sushrut Samhita, E. officinalis is regarded as "the best among rejuvenative herbs." Since ages E. officinalis has been used by practitioners of Ayurvedic system for the treatment of diabetes mellitus in India. Phytochemical investigations of fruits of E. officinalis show that it is having high amount of polyphenol content like low and high molecular weight tannins such as gallic acid, 1-o-galloyl-β-D-glucose, esters of gallic acid, methyl gallate, corilagin, furosin, geraniin, emblicanins A and B, punigluconin, pedunculagin, ellagic acid, and flavonoids such as quercetin in the natural form. ,, Polyphenols such as tannic acid and flavonoids present in number of medicinal plants are reported to have glucose-lowering, , lipid-lowering activities, ,, and anti-oxidant properties.  Therefore, this study was aimed to investigate the possible anti-diabetic and hypolipidemic potential of polyphenol-rich hydroalcoholic extract (HE) of E. officinalis fruit and its relation with anti-oxidant activity.
| Materials and Methods|| |
The fresh fruits of E. officinalis purchased from Gaziabad (Madhya Pradesh, India) were authenticated by Department of Pharmacognosy. HE of fruits was prepared in pharmaceutical laboratory. Streptozotocin (STZ) was purchased from Sigma Chemicals (St. Louis, USA). Glucose, triglyceride, total cholesterol, and cholesterol high-density lipoprotein (HDL) kits were purchased from Span Diagnostics, Baroda, India. Radioimmunoassay kit for rat insulin was obtained from Bhabha Atomic Research Centre, Mumbai, India. Other chemicals used were of analytical reagent grade.
Hydro alcoholic extract preparation
Five hundred grams of the powder of dried fruits of E. Officinalis were extracted exhaustively with water and methanol mixture at 40-60 o C in proportion of 1:1 for 48 h. The HEs thus obtained were filtered and solvent removed under vacuum.
Determination of total polyphenols
HE (100 μl) was mixed with 0.2 ml Folin-Ciocalteu reagent, 2 ml of distilled water and 1 ml of 15% Na 2 CO 3 solution was measured at 765 nm after being kept for 2 h at room temperature. The total polyphenolic content was expressed as milligrams of gallic acid equivalents/1 g extract. 
Male Wistar rats weighing 200-250 g were obtained from the animal facility of Zydus Research Centre, Ahmedabad, India. They were maintained under standard environmental conditions (12 h light/dark cycle at 20-25°C and controlled humidity) and provided with feed and purified water ad libitum. All experiments and protocols (Protocol No: 06/2005) described in this study were approved by Institutions Animal Ethics Committee and are in accordance with guidelines as per "Guide for the care and use of laboratory animal" and with permission from committee for the purpose of control and suppression of experiments on animals.
Diabetes was induced by single intravenous injection of STZ (45 mg/kg) dissolved in freshly prepared 0.1M citrate buffer (pH = 4.5).  To prevent the hypoglycemia that occurred during the first 24 h following the STZ administration, 5% glucose solution was orally given to the diabetic rats. After 48 h of STZ injection, animals showing glucosuria (>2%) were divided into two groups of six rats each: Diabetic control and diabetic treated with HE (100 mg/kg/p.o./day). Further, two more groups one treated with vehicle and another treated with HE (100 mg/kg/po/day) were also included in the study for comparison with diabetes-induced groups. Treatment was started after 3 days of STZ injection and it was given daily for 4 weeks. Daily food, water intake, and body weight gain were measured.
Blood sampling and biochemical analysis
At the end of 4-week treatment, the animals were kept for an overnight fasting and the blood samples were collected from retro-orbital plexus and allowed to clot for 30 min at room temperature. These blood samples were centrifuged at 5000 rpm for 20 min and serum was separated and stored at -20°C until analysis was done. Serum samples were analyzed spectrometrically for serum glucose, triglyceride, total cholesterol, and HDL cholesterol, using their respective kits and an UV-visible spectrophotometer (Shimadzu UV-1601, Japan). Low-density lipoprotein (LDL) and very low-density lipoprotein (VLDL) were calculated from the values of total cholesterol, triglyceride, and HDL. Serum insulin was estimated by a radioimmunoassay technique using the gamma counter (Packard).
The same animals were subjected to Oral glucose tolerance test on next day.  To perform OGTT, the animals were orally administered with 1.5 g/kg of glucose and blood samples were collected from the tail vein under light ether anesthesia before, i.e. 0 min and 30, 60, and 120 min after oral glucose administration. Samples were analyzed spectrometrically for serum glucose, and serum insulin was estimated by a radioimmunoassay technique using the gamma counter. Plotting the glucose concentration versus time gives a curve showing rise and fall in glucose and insulin levels with time and expressed as integrated area under the curve for glucose and insulin (AUC glucose and AUC insulin ).
Assessment of oxidative stress-related markers
Liver tissues were finely sliced and homogenized at 12000 × g in chilled Tris-buffer (pH 7.4). The homogenate was centrifuged and a clear supernatant was used for estimation of various anti-oxidant parameters such as superoxide dismutase (SOD), catalase, lipid peroxidation or malondialdehyde (MDA), and reduced glutathione (GSH). SOD was determined by the method of Mishra and Fridovich,  catalase was determined by the method of Aebi,  and GSH was determined by the method of Moron et al.  MDA formation was determined by the method of Slater and Sawyer.  The result of anti-oxidant activity in liver was expressed in terms of protein content which was measured as per the method of Lowry et al. 
Values are expressed as mean ± SEM. The results were analyzed using one-way factorial analysis of variance (ANOVA) followed by Tukey's multiple comparison test using Graphpad Prism 5 software (GraphPad Software, Inc.). The value of P less than 5% (P < 0.05) was considered statistically significant.
| Results|| |
Effects of hydroalcoholic extract on general features and biochemical parameters
Intravenous injection of STZ produced cardinal signs of type 1 diabetes i.e. loss of body weight, polyphagia, and polydipsia in rats. Chronic treatment with HE significantly (P < 0.05) prevented loss of body weight, polydypsia, and polyphagia in STZ-diabetic rats. There was no significant effect on the food and water intake of non-diabetic rats [Table 1]. STZ-induced diabetic rats were found to exhibit significant hyperglycemia as compared to control rats. Treatment with HE produced significant (P < 0.05) decrease in elevated serum glucose levels. Decrease in serum insulin levels in diabetic rats was increased by the treatment with HE but it is not statistically significant. It did not produce any significant effect on the serum glucose and insulin levels in non-diabetic rats [Table 2]. STZ-induced diabetic rats were found to have significantly (P < 0.05) elevated serum triglyceride, total cholesterol, LDL cholesterol, and VLDL cholesterol levels as compared to non-diabetic control. HDL cholesterol was found to be significantly decreased in diabetic rats. Treatment with HE produced a significant reduction in elevated serum triglyceride, total cholesterol, LDL cholesterol, and VLDL cholesterol levels in diabetic rats. There was an increase in HDL cholesterol; however, it was not statistically significant (P < 0.05). Treatment of non-diabetic rats with HE did not produce any significant effects on lipid profile [Figure 1].
|Figure 1: Effect of chronic treatment with hydroalcoholic extract (HE) of Emblica officinalis in non-diabetic control and diabetic rats. Each bar represents mean ± SEM of six animals. CON-non-diabetic control, COHA-non-diabetic control treated with HE, DIC-diabetic control, and DIHA-diabetic animals treated with HE, *: Significantly different from diabetic control animals (P < 0.05). (ANOVA followed by Tukey's multiple comparison test)|
Click here to view
|Table 1: Effect of hydroalcoholic extract of E. officinalis on general features of non-diabetic control and diabetic rats|
Click here to view
|Table 2: Effect of hydroalcoholic extract of E. officinalis on serum glucose and insulin of non-diabetic control and diabetic rats|
Click here to view
Oral glucose tolerance test
Results of oral glucose tolerance test revealed that AUC glucose is significantly increased in diabetic control as compared to non-diabetic control. Treatment with HE significantly decreased elevated AUC glucose of diabetic animals. AUC insulin of diabetic control was significantly decreased as compared to non-diabetic control group. Treatment with HE did not produce any significant change but produced a slight increase in AUC insulin of diabetic rats as compared to that of diabetic control [Table 2].
Effects of anti-oxidant parameters in liver
STZ-induced diabetic rats were found to have decreased SOD, GSH, and catalase enzyme levels in liver as compared to control. Treatment with HE produced significant increase in these enzyme levels. Treatment of non-diabetic rats with HE did not produce any effect on the SOD levels as compared to control. While there was slight increase in catalase, GSH level was observed to remain unaltered with treatment of HE in non-diabetic rats [Figure 2]. STZ-diabetic rats were found to exhibit significant increase MDA levels in liver as compared to control rats. Treatment with HE produced significant decrease in MDA levels. Treatment of non-diabetic rats with HE did not produce any significant effect on the MDA levels [Figure 2].
|Figure 2: Effect of chronic treatment with hydroalcoholic extract (HE) of E. officinalis on anti-oxidant parameters in non-diabetic control and diabetic rats. Each bar represents mean ± SEM of six animals. CON-non-diabetic control, COHA-non-diabetic control treated with HE, DIC-diabetic control, and DIHA-diabetic animals treated with HE, *: Significantly different from diabetic control animals (P < 0.05). (ANOVA followed by Tukey's multiple comparison test)|
Click here to view
| Discussion|| |
Diabetic rats are reported to have loss of body weight, increased food and water intake which could be due to excessive break-down of tissue proteins and dehydration and catabolism of fats and proteins.  Chronic treatment with HE of E. officinalis to diabetic rat decreased food and water consumption and prevented loss of body weight and this could be due to decrease in catabolic reaction and a better control of the hyperglycemic state in the diabetic rats. The HE of E. officinalis produced decrease in blood glucose levels which indicates that HE possesses anti-diabetic activity. Medicinal plants such as Terminalia catappa fruits, Helichrysum plicatum leaves, Lagerstroemia speciosa leaves, Punica granatum flower, Pterocarpus marsupium bark, green tea, Prunus amygdalus seeds, and red grapes are rich in polyphenols that are reported to be anti-diabetic in various experimental models. ,,, Polyphenols reported to produce anti-diabetic activity not only in diabetic animals but also in diabetic patients.  Results obtained from phytochemical investigation revealed that the HE possessed higher concentration of total phenols (541.3 mg gallic acid equivalent/1 g extract). A good correlation of anti-diabetic activity and polyphenol concentration in HE of E. officinalis was found in our study. Although the HE of E. officinalis produced decrease in glucose levels, it failed to improve STZ induced decrease in serum insulin at significant levels. This suggests that the HE possesses anti-diabetic activity which may be due to increased sensitivity of peripheral tissue to insulin or due to a direct insulin-like effect. The result of OGTT also substantiates the findings that HE produced improvement of glucose metabolism in diabetic rat. Concentrations of lipids, such as cholesterol, triglyceride, LDL cholesterol, and VLDL cholesterol were significantly increased in diabetic rats as compared to normal rats which correlate with previous studies in diabetic patients and diabetic rats which could be due to variety of derangements in metabolic and regulatory mechanisms, due to insulin deficiency, which is responsible for the observed accumulation of lipid. , In this study, chronic treatment with HE of E. officinalis exhibited more potent lowering effect on triglyceride, total cholesterol, LDL, and VLDL. These may be due to inhibition of lipolysis in adipose tissue by insulin sensitizing or insulin mimetic effect of polyphenolic fraction of HE of E. officinalis because insulin sensitizers and insulin mimetics reported to inhibit lipolysis by inhibiting the activity of the hormone sensitive lipases in adipose tissue. Thus, the results of this study indicate that HE of E. officinalis may possess lipid-lowering activity by acting on insulin receptors.
Numerous experimental and clinical observations have indicated that hyperglycemia may directly or indirectly contribute to an increased formation of free radicals. Oxidative stress in diabetes coexists with a reduction in anti-oxidative enzymes such as SOD, GSH, and catalase.  A significant decrease in GSH, SOD, and catalase level was observed, which indicates hyperglycemia decreases anti-oxidant capacity due to the accumulation of superoxide anion radicals and hydrogen peroxide. Treatment with HE produced increase in levels of anti-oxidant enzymes; this may result in reduction of hydrogen peroxides and protect the tissues from highly reactive hydroxyl radicals. Study also showed that the increased level of MDA, a marker of fatty chain peroxidation, was significantly increased in diabetes. The treatment with HE of E. officinalis decreased MDA level significantly in diabetic rats. Many plant extracts and plant products have been shown to possess anti-diabetic activity having significant anti-oxidant activity.  Since E. officinalis contains a large amount of polyphenols, it is found to possess significant anti-oxidant activity. Therefore, the presence of polyphenols may be responsible for the anti-diabetic activity of E. officinalis.
These findings suggest that there can be a correlation between the higher concentration of total polyphenol contents and anti-diabetic, anti-hyperlipidemic, and anti-oxidant activities. Several anti-diabetic and anti-obesity small molecule from natural source with direct or indirect insulin releasing effect on islet cell, direct insulin-like and insulin mimetic effect have been reported. , Most of these compounds bind or activate the insulin receptors and have hypoglycemic and hypolipidemic effects in animals.  The anti-diabetic activity of polyphenols of E. officinalis appears to be mediated through peripheral utilization of glucose either by direct insulin-like or insulin mimetic effect in diabetic conditions. We believe that polyphenols may provide the molecular basis for a new generation of orally deliverable, anti-diabetic molecule with anti-oxidant and anti-hyperlipidemic activities. It distinguishes itself from other drugs by the fact that it not only stimulates glucose transport but also decreases lipid level in diabetes. It is possible that, unlike most other anti-diabetic drugs, HEs of E. officinalis may reduce blood glucose without increasing adiposity.
However, many questions remain to be answered. Polyphenols are still a mixture of hydrolysable tannins and flavonoids. What is the most effective compound in these activities? How polyphenols does produce anti-diabetic activity and mediates the inhibition of cholesterol and triglyceride synthesis? Is polyphenols bioavailable in vivo? Further investigations are required to be carrying out for structural and functional studies.
| Conclusion|| |
Polyphenol-rich HE of E. officinalis ameliorate hyperglycemia, hyperlipidemia, and oxidative stress in animal model of diabetes mellitus. Thus, it can be suggested that the combination of anti-diabetic, anti-hyperlipidemic, and anti-oxidant activities of various polyphenols makes it ideally suited for development of novel phytochemical for the treatment of diabetes mellitus.
| References|| |
|1.||Patel SS, Goyal RK. Emblica officinalis Geart.: A comprehensive review on phytochemistry, pharmacology and ethnomedicinal uses. Res J Med Plant 2012;6:6-16. |
|2.||Kirtikar KR, Basu BD. Emblica officinalis. Indian Medicinal Plants. 11 th ed., vol. 3. Uttaranchal, India: Oriental Enterprises; 1935. p. 1029-30. |
|3.||Zhang YJ, Tanaka T, Yang CR, Kouno I. New phenolic constituents from the fruit juice of Phyllanthus emblica. Chem Pharm Bull (Tokyo) 2001;49:537-40. |
|4.||Kumaran A, Karunakaran RJ. Nitric oxide radical scavenging active components from Phyllanthus emblica L. Plant Foods Hum Nutr 2006;61:1-5. |
|5.||Anila L, Vijayalakshmi NR. Antioxident action of flavonoids from Mangifera indica and Emblica officinalis in hypercholesterolemic rats. Food Chem 2003;83:569-74. |
|6.||Iwai K. Antidiabetic and antioxidant effects of polyphenols in brown alga Ecklonia stolonifera in genetically diabetic KK-A (y) mice. Plant Foods Hum Nutr 2008;63:163-9. |
|7.||El-Alfy AT, Ahmed AA, Fatani AJ. Protective effect of red grape seeds proanthocyanidins against induction of diabetes by alloxan in rats. Pharmacol Res 2005;52:264-70. |
|8.||Anila L, Vijayalakshmi NR. Flavonoids from Emblica officinalis and Mangifera indica-effectiveness for dyslipidemia. J Ethnopharmacol 2002;79:81-7. |
|9.||Liu X, Kim JK, Li Y, Li J, Liu F, Chen X. Tannic acid stimulates glucose transport and inhibits adipocyte differentiation in 3T3-L1 cells. J Nutr 2005;135:165-71. |
|10.||Yugarani T, Tan BK, Das NP. The effects of tannic acid on serum and liver lipids of RAIF and RICO rats fed on high fat diet. Comp Biochem Physiol Comp Physiol 1993;104:339-43. |
|11.||Croft KD. The chemistry and biological effects of flavonoids and phenolic acids. Ann N Y Acad Sci 1998;854:435-42. |
|12.||Gao X, Ohlander M, Jeppsson N, Björk L, Trajkovski V. Changes in antioxidant effects and their relationship to phytonutrients in fruits of sea buckthorn (Hippophae rhamnoides L.) during maturation. J Agric Food Chem 2000;48:1485-90. |
|13.||Patel SS, Goyal RK. Prevention of diabetes-induced myocardial dysfunction in rats using the juice of the Emblica officinalis fruit. Exp Clin Cardiol 2011;16:87-91. |
|14.||Olefsky JM. LIlly lecture 1980. Insulin resistance and insulin action. An in vitro and in vivo perspective. Diabetes 1981;30:148-62. |
|15.||Misra HP, Fridovich I. The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase. J Biol Chem 1972;247:3170-5. |
|16.||Aebi H. Oxidoreductases acting on groups other than CHOH: Catalase. In: Colowick SP, Kaplan NO, Packer L, editors. Methods in Enzymology. London: Academic Press; 1984. p. 121-5. |
|17.||Moron MS, Depierre JW, Mannervik B. Levels of glutathione, glutathione reductase and glutathione S-transferase activities in rat lung and liver. Biochim Biophys Acta 1979;582:67-78. |
|18.||Slater TF, Sawyer BC. The stimulatory effects of carbon tetrachloride and other halogenoalkanes on peroxidative reactions in rat liver fractions in vitro. General features of the systems used. Biochem J 1971;123:805-14. |
|19.||Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193:265-75. |
|20.||Chatterjea MN, Shinde R. Metabolism of Proteins and Amino acids. Textbook of Medical Biochemistry. New Delhi: Jaypee Brothers, Medical Publishers Pvt. Ltd.; 2002. p. 437-495. |
|21.||Aslan M, Deliorman Orhan D, Orhan N, Sezik E, Yesilada E. In vivo antidiabetic and antioxidant potential of Helichrysum plicatum ssp. plicatum capitulums in streptozotocin-induced-diabetic rats. J Ethnopharmacol 2007;109:54-9. |
|22.||Liu F, Kim J, Li Y, Liu X, Li J, Chen X. An extract of Lagerstroemia speciosa L. has insulin-like glucose uptake-stimulatory and adipocyte differentiation-inhibitory activities in 3T3-L1 cells. J Nutr 2001;131:2242-7. |
|23.||Al-Awwadi N, Azay J, Poucheret P, Cassanas G, Krosniak M, Auger C, et al. Antidiabetic activity of red wine polyphenolic extract, ethanol, or both in streptozotocin-treated rats. J Agric Food Chem 2004;52:1008-16. |
|24.||Huang TH, Peng G, Kota BP, Li GQ, Yamahara J, Roufogalis BD, et al. Anti-diabetic action of Punica granatum flower extract: Activation of PPAR-gamma and identification of an active component. Toxicol Appl Pharmacol 2005;207:160-9. |
|25.||Kusirisin W, Srichairatanakool S, Lerttrakarnnon P, Lailerd N, Suttajit M, Jaikang C, et al. Antioxidative activity, polyphenolic content and anti-glycation effect of some Thai medicinal plants traditionally used in diabetic patients. Med Chem 2009;5:139-47. |
|26.||Bakhotmah BA, Alzahrani HA. Self-reported use of complementary and alternative medicine (CAM) products in topical treatment of diabetic foot disorders by diabetic patients in Jeddah, Western Saudi Arabia. BMC Res Notes 2010;3:254-61. |
|27.||Kaleem M, Asif M, Ahmed QU, Bano B. Antidiabetic and antioxidant activity of Annona squamosa extract in streptozotocin-induced diabetic rats. Singapore Med J 2006;47:670-5. |
|28.||Pitocco D, Zaccardi F, Di Stasio E, Romitelli F, Santini SA, Zuppi C, et al. Oxidative stress, nitric oxide, and diabetes. Rev Diabet Stud 2010;7:15-25. |
|29.||Scartezzini P, Antognoni F, Raggi MA, Poli F, Sabbioni C. Vitamin C content and antioxidant activity of the fruit and of the Ayurvedic preparation of Emblica officinalis Gaertn. J Ethnopharmacol 2006;104:113-8. |
|30.||Manchem VP, Goldfine ID, Kohanski RA, Cristobal CP, Lum RT, Schow SR, et al. A novel small molecule that directly sensitizes the insulin receptor in vitro and in vivo. Diabetes 2001;50:824-30. |
|31.||Nagareddy PR, Vasudevan H, McNeill JH. Oral administration of sodium tungstate improves cardiac performance in streptozotocin-induced diabetic rats. Can J Physiol Pharmacol 2005;83:405-11. |
|32.||Rieusset J, Touri F, Michalik L, Escher P, Desvergne B, Niesor E, et al. A new selective peroxisome proliferator-activated receptor gamma antagonist with antiobesity and antidiabetic activity. Mol Endocrinol 2002;16:2628-44. |
[Figure 1], [Figure 2]
[Table 1], [Table 2]
|This article has been cited by|
||Antidiabetic potential of gallic acid from Emblica officinalis: improved glucose transporters and insulin sensitivity through PPAR-? and Akt signaling
| ||Bhavesh C Variya,Anita K Bakrania,Snehal S Patel |
| ||Phytomedicine. 2019; : 152906 |
|[Pubmed] | [DOI]|
||Suppression of abdominal fat and anti-hyperlipidemic potential of Emblica officinalis: Upregulation of PPARs and identification of active moiety
| ||Bhavesh C. Variya,Anita K. Bakrania,Yuanli Chen,Jihong Han,Snehal S. Patel |
| ||Biomedicine & Pharmacotherapy. 2018; 108: 1274 |
|[Pubmed] | [DOI]|
||Ellagic acid in Emblica officinalis exerts anti-diabetic activity through the action on ß-cells of pancreas
| ||Noor Fatima,Rahman M. Hafizur,Abdul Hameed,Shakil Ahmed,Maliha Nisar,Nurul Kabir |
| ||European Journal of Nutrition. 2017; 56(2): 591 |
|[Pubmed] | [DOI]|
||Functional food supplements to ameliorate the secondary complications in high fructose fed diabetic rats
| ||S. S. Gite,S. A. Yadav,S. S. Nilegaonkar,V. V. Agte |
| ||Food Funct.. 2017; |
|[Pubmed] | [DOI]|
||Emblica officinalis (Amla): A review for its phytochemistry, ethnomedicinal uses and medicinal potentials with respect to molecular mechanisms
| ||Bhavesh C. Variya,Anita K. Bakrania,Snehal S. Patel |
| ||Pharmacological Research. 2016; |
|[Pubmed] | [DOI]|
||Evaluation of “GSPF kwath”: A Gymnema sylvestre-containing polyherbal formulation for the treatment of human type 2 diabetes mellitus
| ||Sunil Mahajan,Pratibha Chauhan,Senthil Kumar Subramani,Ashwinee Anand,Dinesh Borole,Harimohan Goswamy,Prasad GBKS |
| ||European Journal of Integrative Medicine. 2015; |
|[Pubmed] | [DOI]|